Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
docetaxel (taxotere) (1 trial)
gimeracil (5 trials)
irinotecan (Camptosar) (2 trials)
oteracil (5 trials)
s-1 (5 trials)
tegafur (5 trials)
bevacizumab (avastin) (1 trial)
cetuximab (erbitux) (1 trial)
fluorouracil (efudex) (1 trial)
gemcitabine (gemzar) (1 trial)
leucovorin (1 trial)
oxaliplatin (eloxatin) (2 trials)
Carcinoma (Phase 2)
Colorectal Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Rectal Neoplasms (Phase 2)
Stomach Neoplasms (Phase 3)
Trials (6 total)
Trial APIs (12 total)